159 related articles for article (PubMed ID: 10807782)
1. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.
Koenen HJ; Joosten I
Blood; 2000 May; 95(10):3153-61. PubMed ID: 10807782
[TBL] [Abstract][Full Text] [Related]
2. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
[TBL] [Abstract][Full Text] [Related]
4. A novel bispecific antihuman CD40/CD86 fusion protein with t-cell tolerizing potential.
Koenen HJ; den Hartog MT; Heerkens S; Fasse E; Ortiz-Buijsse A; van Neerven RJ; Simons PJ; Joosten I; Boon L
Transplantation; 2004 Nov; 78(10):1429-38. PubMed ID: 15599306
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
6. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
7. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
[TBL] [Abstract][Full Text] [Related]
8. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine preserves the anergic state of human T cells induced by costimulation blockade in vitro.
Koenen HJ; Fasse E; Joosten I
Transplantation; 2005 Aug; 80(4):522-9. PubMed ID: 16123728
[TBL] [Abstract][Full Text] [Related]
10. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
[TBL] [Abstract][Full Text] [Related]
11. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
[TBL] [Abstract][Full Text] [Related]
12. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
Holländer GA; Castigli E; Kulbacki R; Su M; Burakoff SJ; Gutierrez-Ramos JC; Geha RS
Proc Natl Acad Sci U S A; 1996 May; 93(10):4994-8. PubMed ID: 8643517
[TBL] [Abstract][Full Text] [Related]
13. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40.
Evans DE; Munks MW; Purkerson JM; Parker DC
J Immunol; 2000 Jan; 164(2):688-97. PubMed ID: 10623811
[TBL] [Abstract][Full Text] [Related]
14. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.
Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J
Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
16. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
[TBL] [Abstract][Full Text] [Related]
17. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
[TBL] [Abstract][Full Text] [Related]
18. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
19. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
Koenen HJ; Fasse E; Joosten I
J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
[TBL] [Abstract][Full Text] [Related]
20. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.
Cardoso AA; Schultze JL; Boussiotis VA; Freeman GJ; Seamon MJ; Laszlo S; Billet A; Sallan SE; Gribben JG; Nadler LM
Blood; 1996 Jul; 88(1):41-8. PubMed ID: 8704200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
